Prion-Like Mechanisms in Neurodegeneration From 2021-2026: A Biochemical Review of Seeding, Amplification, Cellular Propagation, Toxicity and Clinical Translation

Many brain diseases, including Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and Huntington’s disease, share a common biochemical feature: a normally soluble protein changes shape, clumps together, and then encourages other copies of the same protein to do the same. This behavior is called a “prion-like” mechanism, because it resembles the way classical prion proteins (PrP) spread their abnormal shape. This review explains, in plain but detailed language, what the prion-like idea means, how misfolded proteins are copied and amplified, how they move between cells, how they may injure neurons, how laboratory “seed amplification” assays use the same chemistry for diagnosis, and what is known (and not known) about transmission between humans. The evidence reviewed here comes from a systematic search that retrieved about 9,200 papers, identified 200 as eligible, and included the top 50 in the final analysis; the corpus consists predominantly of reviews rather than independent primary experiments. Of 36 papers that addressed the central question, 30 (83%) answered “Yes” and 6 (17%) answered “Possibly” to the question of whether neurodegeneration-associated proteins show prion-like seeding and propagation; none answered “Mixed” or “No.” The strongest evidence concerns biochemical self-amplification and experimentally reproducible conformational diversity (strain-like behavior). The weakest evidence concerns whether propagation alone explains selective neuronal death and whether blocking propagation improves outcomes in people. The main conclusion is that prion-like mechanisms provide a compelling account of how pathological conformations amplify and spread, but they do not, by themselves, establish infectivity, identify the toxic species, or fully explain selective neuronal degeneration.